Stocks expected to have increasing option volume: NVDA UNH JNJ BAC GS C SCHW PNC STT ACI WBA COTY
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
UnitedHealth Group (UNH) PT Lowered to $595 at RBC Capital
October 16, 2024 6:51 AM EDTRBC Capital analyst Ben Hendrix lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $615.00) while maintaining a Outperform rating.
The analyst comments "We raise our 2025 MCR estimate by 70 bps and lower our adjusted EPS estimate to $29.75, which should approximate the... More
UnitedHealth Group (UNH) PT Lowered to $625 at Truist Securities
October 16, 2024 6:36 AM EDTTruist Securities analyst David MacDonald lowered the price target on UnitedHealth Group (NYSE: UNH) to $625.00 (from $640.00) while maintaining a Buy rating.
The analyst comments "While UNH reported mixed 3Q results marked by a higher MLR, tightened 2024 guidance and provided a more conservative first glance at... More
UnitedHealth Group (UNH) PT Lowered to $595 at Deutsche Bank
October 16, 2024 6:17 AM EDTDeutsche Bank analyst George Hill lowered the price target on UnitedHealth Group (NYSE: UNH) to $595.00 (from $632.00) while maintaining a Buy rating.
The analyst comments "Initial 2025 Outlook Comes Up Light: UNH reported F3Q results where the company first commented on its 2025 EPS outlook, with the initial guidance of ~ $30 in EPS being ~4% below the Streets ~$31.25 and the ~8% growth... More



